Clinical Trials Browser

LY2784544 × Clear all

NCT01594723 2025-07-23

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Phase 2 Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT01134120 2018-04-17

A Study in Myeloproliferative Disorders

Phase 1 Completed

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT01520220 2017-04-12

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

Phase 1 Completed

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis